Advertisement
Advertisement

LXEO

LXEO logo

Lexeo Therapeutics, Inc. Common Stock

4.81
USD
Sponsored
+0.26
+5.71%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

4.82

+0.01
+0.21%

Lexeo Therapeutics, Inc. Common Stock Profile

About

Lexeo Therapeutics is a clinical-stage genetic medicine company which defined cardiovascular diseases and APOE4-associated Alzheimer's disease are treated. Lexeo Therapeutics is based in New York City.

Info & Links

CEO

R. Nolan Townsend

Headquarters

345 PARK AVENUE SOUTH, FLOOR 6
NEW YORK, NY 10010, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.lexeotx.com

Auditor

KPMG LLP

Share holders

19

Employees

59

Lexeo Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

378.47M

Enterprise Value

307.43M

Enterprise Value/EBITDA(ttm)

-3.15

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.63

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-47.48%

Return on Invested Capital(ttm)

-52.72%

Return on Assets(ttm)

-41.72%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-97.45M

Net Income Available to Common(ttm)

-87.50M

Diluted EPS(ttm)

-1.45

Share Statistics

Beta (5Y Monthly)

1.46

52-Week Change

8.09%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

78.52M

Dividend Yield

0.00%

Float4

76.95M

% Held by Insiders

2.00%

% Held by Institutions

60.67%

Balance Sheet

Total Cash(mrq)

193.04M

Total Cash Per Share(mrq)

2.46

Total Debt(mrq)

726.00K

Total Debt/Equity(mrq)

0.31%

Current Ratio(mrq)

14.16%

Quick Ratio(mrq)

14.16%

Book Value Per Share(mrq)

3.12

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.26

Free Cash Flow(ytd)

-21.18M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement